Quarterly Research Grant Funding Programme

Quarterly Research Grant Funding Programme

This programme primarily funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s. We do not fund research which is directed at symptomatic relief.

For preclinical research, we fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years.

For clinical research, we fund clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact us ahead of submission if you are thinking of applying for a clinical trial.

We fund internationally and accept applications from academics and commercial entities. However, the costs in commercial applications should be equivalent to academic costs.

Our full Research Strategy provides more information on the types of research we fund, our funding priorities and how we provide funding.

Please read through the resources below before applying for funding. If you have any questions regarding whether your project fits our narrow remit, please contact our research team.

How does our application process work?

If the proposed project falls within Cure Parkinson’s scope for funding, it will be considered by our independent research committee, which meets on a quarterly basis.

At each meeting, the committee discuss new applications and decide whether they should be evaluated further. If they decide that an application should be considered for funding, the application will be sent for external peer review. The feedback from these expert reviews will be discussed at the next research committee meeting, and a recommendation on whether to fund the project will be made for the Cure Parkinson’s trustees to consider. For successful applicants, the process takes approximately 3-4 months but can take longer, particularly for clinical trials where an iterative approach may apply.